Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Biopump: Autologous skin-derived micro-organ genetically engineered to provide sustained continuous secretion of therapeutic proteins.

Mitrani E, Pearlman A, Stern B, Miari R, Goltsman H, Kunicher N, Panet A.

Dermatol Ther. 2011 Sep-Oct;24(5):489-97. doi: 10.1111/j.1529-8019.2012.01457.x.

PMID:
22353155
2.

Preclinical and Preliminary Clinical Evaluation of Genetically Transduced Dermal Tissue Implants for the Sustained Secretion of Erythropoietin and Interferon α.

Shapir N, Miari R, Blum S, Schwartz D, Chernin G, Neil GA, Afik D, Panet A.

Hum Gene Ther Clin Dev. 2015 Dec;26(4):216-27. doi: 10.1089/humc.2015.125.

PMID:
26684446
3.

The skin as a biofactory for systemic secretion of erythropoietin: potential of genetically modified keratinocytes and fibroblasts.

Scheidemann F, Löser M, Niedermeier A, Kromminga A, Therrien JP, Vogel J, Pfützner W.

Exp Dermatol. 2008 Jun;17(6):481-8. doi: 10.1111/j.1600-0625.2007.00680.x. Epub 2008 Mar 6.

PMID:
18331333
4.

Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins.

Brill-Almon E, Stern B, Afik D, Kaye J, Langer N, Bellomo S, Shavit M, Pearlman A, Lippin Y, Panet A, Shani N.

Mol Ther. 2005 Aug;12(2):274-82.

5.

Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors.

Matsui H, Shibata M, Brown B, Labelle A, Hegadorn C, Andrews C, Hebbel RP, Galipeau J, Hough C, Lillicrap D.

Stem Cells. 2007 Oct;25(10):2660-9. Epub 2007 Jul 5.

6.

Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.

Indraccolo S, Habeler W, Tisato V, Stievano L, Piovan E, Tosello V, Esposito G, Wagner R, Uberla K, Chieco-Bianchi L, Amadori A.

Cancer Res. 2002 Nov 1;62(21):6099-107.

7.

Human erythropoietin gene therapy for patients with chronic renal failure.

Lippin Y, Dranitzki-Elhalel M, Brill-Almon E, Mei-Zahav C, Mizrachi S, Liberman Y, Iaina A, Kaplan E, Podjarny E, Zeira E, Harati M, Casadevall N, Shani N, Galun E.

Blood. 2005 Oct 1;106(7):2280-6. Epub 2005 Mar 29.

8.

Lentiviral vector-mediated gene transfer to endotherial cells compared with adenoviral and retroviral vectors.

Sakoda T, Kasahara N, Kedes L, Ohyanagi M.

Prep Biochem Biotechnol. 2007;37(1):1-11.

PMID:
17134978
9.

Syngeneic central nervous system transplantation of genetically transduced mature, adult astrocytes.

Selkirk SM, Greenberg SJ, Plunkett RJ, Barone TA, Lis A, Spence PO.

Gene Ther. 2002 Apr;9(7):432-43.

10.

Gene therapy in skin: choosing the optimal viral vector.

Teo EH, Cross KJ, Bomsztyk ED, Lyden DC, Spector JA.

Ann Plast Surg. 2009 May;62(5):576-80. doi: 10.1097/SAP.0b013e31819fafbd.

PMID:
19387165
11.

Solid tissues can be manipulated ex vivo and used as vehicles for gene therapy.

Hasson E, Slovatizky Y, Shimoni Y, Falk H, Panet A, Mitrani E.

J Gene Med. 2005 Jul;7(7):926-35.

PMID:
15744776
12.
13.

Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.

Virk MS, Conduah A, Park SH, Liu N, Sugiyama O, Cuomo A, Kang C, Lieberman JR.

Bone. 2008 May;42(5):921-31. doi: 10.1016/j.bone.2007.12.216. Epub 2008 Jan 5.

PMID:
18295562
14.

Preclinical and preliminary clinical evaluation of genetically transduced dermal tissue implants for the sustained secretion of erythropoietin and interferon α.

Shapir N, Miari R, Blum S, Schwartz D, Chernin G, Neil G, Afik D, Panet A.

Hum Gene Ther Clin Dev. 2015 Dec 9. [Epub ahead of print]

PMID:
26650479
15.

A large preclinical animal model to assess ex vivo skin gene therapy applications.

Pfützner W, Joari MR, Foster RA, Vogel JC.

Arch Dermatol Res. 2006 Jun;298(1):16-22. Epub 2006 Mar 25.

PMID:
16565820
17.
18.

Gene therapy for long-term expression of erythropoietin in rats.

Osborne WR, Ramesh N, Lau S, Clowes MM, Dale DC, Clowes AW.

Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):8055-8.

19.

Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.

Cheng J, Sun J, Sung RS.

Transpl Immunol. 2009 May;21(1):33-42. doi: 10.1016/j.trim.2009.02.001. Epub 2009 Feb 15.

PMID:
19224710
20.

Gene therapy of ovarian cancer with IFN-alpha-producing fibroblasts: comparison of constitutive and inducible vectors.

Indraccolo S, Moserle L, Tisato V, Gola E, Minuzzo S, Roni V, Persano L, Chieco-Bianchi L, Amadori A.

Gene Ther. 2006 Jun;13(12):953-65. Epub 2006 Mar 2.

PMID:
16511522

Supplemental Content

Support Center